4
Cherney, David Z I, Dekkers, Claire C J, Barbour, Sean J, Cattran, Daniel, Abdul Gafor, Abdul Halim, Greasley, Peter J, Laverman, Gozewijn D, Lim, Soo Kun, Di Tanna, Gian Luca, Reich, Heather N, Vervloet, Marc G, Wong, Muh Geot, Gansevoort, Ron T, Heerspink, Hiddo J L
Veröffentlicht in: DIAMOND investigators , Cherney , D Z I , Dekkers , C C J , Barbour , S J , Cattran , D , Abdul Gafor , A H , Greasley , P J , Laverman , G D , Lim , S K , Di Tanna , G L , Reich , H N , Vervloet , M G , Wong , M G , Gansevoort , R T & Heerspink , H J L 2020 , ' Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND) : a randomised, double-blind, crossover trial ' , Lancet Diabetes & Endocrinology , vol. 8 , no. 7 , pp. 582-593 . https://doi.org/10.1016/S2213-8587(20)30162-5;
2020
6
7
8
Macdonald, Thomas M, Hawkey, Chris J, Ford, Ian, McMurray, John J V, Scheiman, James M, Hallas, Jesper, Findlay, Evelyn, Grobbee, Diederick E, Hobbs, F D Richard, Ralston, Stuart H, Reid, David M, Walters, Matthew R, Webster, John, Ruschitzka, Frank, Ritchie, Lewis D, Perez-Gutthann, Susana, Connolly, Eugene, Greenlaw, Nicola, Wilson, Adam, Wei, Li, Mackenzie, Isla S
Veröffentlicht in: Macdonald , T M , Hawkey , C J , Ford , I , McMurray , J J V , Scheiman , J M , Hallas , J , Findlay , E , Grobbee , D E , Hobbs , F D R , Ralston , S H , Reid , D M , Walters , M R , Webster , J , Ruschitzka , F , Ritchie , L D , Perez-Gutthann , S , Connolly , E , Greenlaw , N , Wilson , A , Wei , L & Mackenzie , I S 2017 , ' Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib : the Standard care vs. Celecoxib Outcome Trial (SCOT) ' , European Heart Journal , vol. 38 , no. 23 , pp. 1843-1850 . https://doi.org/10.1093/eurheartj/ehw387;
2017